Full Text of HB6459 96th General Assembly
HB6459eng 96TH GENERAL ASSEMBLY
|
|
|
HB6459 Engrossed |
|
LRB096 21101 RLC 36952 b |
|
| 1 |
| AN ACT concerning criminal law.
| 2 |
| Be it enacted by the People of the State of Illinois, | 3 |
| represented in the General Assembly:
| 4 |
| Section 5. The Illinois Controlled Substances Act is | 5 |
| amended by changing Section 204 as follows: | 6 |
| (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204) | 7 |
| Sec. 204. (a) The controlled substances listed in this | 8 |
| Section are
included in Schedule I. | 9 |
| (b) Unless specifically excepted or unless listed in | 10 |
| another
schedule, any of the following opiates, including their | 11 |
| isomers,
esters, ethers, salts, and salts of isomers, esters, | 12 |
| and ethers,
whenever the existence of such isomers, esters, | 13 |
| ethers and salts is
possible within the specific chemical | 14 |
| designation: | 15 |
| (1) Acetylmethadol; | 16 |
| (1.1) Acetyl-alpha-methylfentanyl | 17 |
| (N-[1-(1-methyl-2-phenethyl)-
| 18 |
| 4-piperidinyl]-N-phenylacetamide); | 19 |
| (2) Allylprodine; | 20 |
| (3) Alphacetylmethadol, except
| 21 |
| levo-alphacetylmethadol (also known as levo-alpha-
| 22 |
| acetylmethadol, levomethadyl acetate, or LAAM); | 23 |
| (4) Alphameprodine; |
|
|
|
HB6459 Engrossed |
- 2 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (5) Alphamethadol; | 2 |
| (6) Alpha-methylfentanyl
| 3 |
| (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| 4 |
| propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| 5 |
| propanilido) piperidine; | 6 |
| (6.1) Alpha-methylthiofentanyl
| 7 |
| (N-[1-methyl-2-(2-thienyl)ethyl-
| 8 |
| 4-piperidinyl]-N-phenylpropanamide); | 9 |
| (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); | 10 |
| (7.1) PEPAP
| 11 |
| (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); | 12 |
| (8) Benzethidine; | 13 |
| (9) Betacetylmethadol; | 14 |
| (9.1) Beta-hydroxyfentanyl
| 15 |
| (N-[1-(2-hydroxy-2-phenethyl)-
| 16 |
| 4-piperidinyl]-N-phenylpropanamide); | 17 |
| (10) Betameprodine; | 18 |
| (11) Betamethadol; | 19 |
| (12) Betaprodine; | 20 |
| (13) Clonitazene; | 21 |
| (14) Dextromoramide; | 22 |
| (15) Diampromide; | 23 |
| (16) Diethylthiambutene; | 24 |
| (17) Difenoxin; | 25 |
| (18) Dimenoxadol; | 26 |
| (19) Dimepheptanol; |
|
|
|
HB6459 Engrossed |
- 3 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (20) Dimethylthiambutene; | 2 |
| (21) Dioxaphetylbutyrate; | 3 |
| (22) Dipipanone; | 4 |
| (23) Ethylmethylthiambutene; | 5 |
| (24) Etonitazene; | 6 |
| (25) Etoxeridine; | 7 |
| (26) Furethidine; | 8 |
| (27) Hydroxpethidine; | 9 |
| (28) Ketobemidone; | 10 |
| (29) Levomoramide; | 11 |
| (30) Levophenacylmorphan; | 12 |
| (31) 3-Methylfentanyl
| 13 |
| (N-[3-methyl-1-(2-phenylethyl)-
| 14 |
| 4-piperidyl]-N-phenylpropanamide); | 15 |
| (31.1) 3-Methylthiofentanyl
| 16 |
| (N-[(3-methyl-1-(2-thienyl)ethyl-
| 17 |
| 4-piperidinyl]-N-phenylpropanamide); | 18 |
| (32) Morpheridine; | 19 |
| (33) Noracymethadol; | 20 |
| (34) Norlevorphanol; | 21 |
| (35) Normethadone; | 22 |
| (36) Norpipanone; | 23 |
| (36.1) Para-fluorofentanyl
| 24 |
| (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| 25 |
| 4-piperidinyl]propanamide); | 26 |
| (37) Phenadoxone; |
|
|
|
HB6459 Engrossed |
- 4 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (38) Phenampromide; | 2 |
| (39) Phenomorphan; | 3 |
| (40) Phenoperidine; | 4 |
| (41) Piritramide; | 5 |
| (42) Proheptazine; | 6 |
| (43) Properidine; | 7 |
| (44) Propiram; | 8 |
| (45) Racemoramide; | 9 |
| (45.1) Thiofentanyl
| 10 |
| (N-phenyl-N-[1-(2-thienyl)ethyl-
| 11 |
| 4-piperidinyl]-propanamide); | 12 |
| (46) Tilidine; | 13 |
| (47) Trimeperidine; | 14 |
| (48) Beta-hydroxy-3-methylfentanyl (other name:
| 15 |
| N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| 16 |
| N-phenylpropanamide). | 17 |
| (c) Unless specifically excepted or unless listed in | 18 |
| another
schedule, any of the following opium derivatives, its | 19 |
| salts, isomers
and salts of isomers, whenever the existence of | 20 |
| such salts, isomers and
salts of isomers is possible within the | 21 |
| specific chemical designation: | 22 |
| (1) Acetorphine; | 23 |
| (2) Acetyldihydrocodeine; | 24 |
| (3) Benzylmorphine; | 25 |
| (4) Codeine methylbromide; | 26 |
| (5) Codeine-N-Oxide; |
|
|
|
HB6459 Engrossed |
- 5 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (6) Cyprenorphine; | 2 |
| (7) Desomorphine; | 3 |
| (8) Diacetyldihydromorphine (Dihydroheroin); | 4 |
| (9) Dihydromorphine; | 5 |
| (10) Drotebanol; | 6 |
| (11) Etorphine (except hydrochloride salt); | 7 |
| (12) Heroin; | 8 |
| (13) Hydromorphinol; | 9 |
| (14) Methyldesorphine; | 10 |
| (15) Methyldihydromorphine; | 11 |
| (16) Morphine methylbromide; | 12 |
| (17) Morphine methylsulfonate; | 13 |
| (18) Morphine-N-Oxide; | 14 |
| (19) Myrophine; | 15 |
| (20) Nicocodeine; | 16 |
| (21) Nicomorphine; | 17 |
| (22) Normorphine; | 18 |
| (23) Pholcodine; | 19 |
| (24) Thebacon. | 20 |
| (d) Unless specifically excepted or unless listed in | 21 |
| another
schedule, any material, compound, mixture, or | 22 |
| preparation which contains
any quantity of the following | 23 |
| hallucinogenic substances, or which
contains any of its salts, | 24 |
| isomers and salts of isomers, whenever the
existence of such | 25 |
| salts, isomers, and salts of isomers is possible
within the | 26 |
| specific chemical designation (for the purposes of this
|
|
|
|
HB6459 Engrossed |
- 6 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| paragraph only, the term "isomer" includes the optical, | 2 |
| position and
geometric isomers): | 3 |
| (1) 3,4-methylenedioxyamphetamine
| 4 |
| (alpha-methyl,3,4-methylenedioxyphenethylamine,
| 5 |
| methylenedioxyamphetamine, MDA); | 6 |
| (1.1) Alpha-ethyltryptamine
| 7 |
| (some trade or other names: etryptamine;
| 8 |
| MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| 9 |
| 3-(2-aminobutyl)indole; a-ET; and AET); | 10 |
| (2) 3,4-methylenedioxymethamphetamine (MDMA); | 11 |
| (2.1) 3,4-methylenedioxy-N-ethylamphetamine
| 12 |
| (also known as: N-ethyl-alpha-methyl-
| 13 |
| 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| 14 |
| and MDEA); | 15 |
| (2.2) N-Benzylpiperazine (BZP); | 16 |
| (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA); | 17 |
| (4) 3,4,5-trimethoxyamphetamine (TMA); | 18 |
| (5) (Blank); | 19 |
| (6) Diethyltryptamine (DET); | 20 |
| (7) Dimethyltryptamine (DMT); | 21 |
| (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP); | 22 |
| (9) Ibogaine (some trade and other names:
| 23 |
| 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| 24 |
| 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| 25 |
| indole; Tabernanthe iboga); | 26 |
| (10) Lysergic acid diethylamide; |
|
|
|
HB6459 Engrossed |
- 7 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (10.5) Salvia divinorum (meaning all parts of the plant | 2 |
| presently classified
botanically as Salvia divinorum, | 3 |
| whether growing or not, the
seeds thereof, any extract from | 4 |
| any part of that plant, and every compound,
manufacture, | 5 |
| salts, isomers, and salts of
isomers whenever the existence | 6 |
| of such salts, isomers, and salts of
isomers is possible | 7 |
| within the specific chemical designation, derivative, | 8 |
| mixture, or preparation of that plant, its
seeds or | 9 |
| extracts);
| 10 |
| (11) 3,4,5-trimethoxyphenethylamine (Mescaline); | 11 |
| (12) Peyote (meaning all parts of the plant presently | 12 |
| classified
botanically as Lophophora williamsii
Lemaire, | 13 |
| whether growing or not, the
seeds thereof, any extract from | 14 |
| any part of that plant, and every compound,
manufacture, | 15 |
| salts, derivative, mixture, or preparation of that plant, | 16 |
| its
seeds or extracts); | 17 |
| (13) N-ethyl-3-piperidyl benzilate (JB 318); | 18 |
| (14) N-methyl-3-piperidyl benzilate; | 19 |
| (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| 20 |
| (also known as N-hydroxy-alpha-methyl-
| 21 |
| 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); | 22 |
| (15) Parahexyl; some trade or other names:
| 23 |
| 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| 24 |
| dibenzo (b,d) pyran; Synhexyl; | 25 |
| (16) Psilocybin; | 26 |
| (17) Psilocyn; |
|
|
|
HB6459 Engrossed |
- 8 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (18) Alpha-methyltryptamine (AMT); | 2 |
| (19) 2,5-dimethoxyamphetamine
| 3 |
| (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); | 4 |
| (20) 4-bromo-2,5-dimethoxyamphetamine
| 5 |
| (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| 6 |
| 4-bromo-2,5-DMA); | 7 |
| (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| 8 |
| Some trade or other names: 2-(4-bromo-
| 9 |
| 2,5-dimethoxyphenyl)-1-aminoethane;
| 10 |
| alpha-desmethyl DOB, 2CB, Nexus; | 11 |
| (21) 4-methoxyamphetamine
| 12 |
| (4-methoxy-alpha-methylphenethylamine;
| 13 |
| paramethoxyamphetamine; PMA); | 14 |
| (22) (Blank); | 15 |
| (23) Ethylamine analog of phencyclidine.
| 16 |
| Some trade or other names:
| 17 |
| N-ethyl-1-phenylcyclohexylamine,
| 18 |
| (1-phenylcyclohexyl) ethylamine,
| 19 |
| N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE; | 20 |
| (24) Pyrrolidine analog of phencyclidine. Some trade | 21 |
| or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | 22 |
| PHP; | 23 |
| (25) 5-methoxy-3,4-methylenedioxy-amphetamine; | 24 |
| (26) 2,5-dimethoxy-4-ethylamphetamine
| 25 |
| (another name: DOET); | 26 |
| (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
|
|
|
HB6459 Engrossed |
- 9 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (another name: TCPy); | 2 |
| (28) (Blank); | 3 |
| (29) Thiophene analog of phencyclidine (some trade
| 4 |
| or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| 5 |
| 2-thienyl analog of phencyclidine; TPCP; TCP); | 6 |
| (30) Bufotenine (some trade or other names:
| 7 |
| 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| 8 |
| 3-(2-dimethylaminoethyl)-5-indolol;
| 9 |
| 5-hydroxy-N,N-dimethyltryptamine;
| 10 |
| N,N-dimethylserotonin; mappine) ; . | 11 |
| (31) 1-Pentyl-3-(1-naphthoyl)indole | 12 |
| Some trade or other names: JWH-018; | 13 |
| (32) 1-Butyl-3-(1-naphthoyl)indole | 14 |
| Some trade or other names: JWH-073. | 15 |
| (e) Unless specifically excepted or unless listed in | 16 |
| another
schedule, any material, compound, mixture, or | 17 |
| preparation which contains
any quantity of the following | 18 |
| substances having a depressant effect on
the central nervous | 19 |
| system, including its salts, isomers, and salts of
isomers | 20 |
| whenever the existence of such salts, isomers, and salts of
| 21 |
| isomers is possible within the specific chemical designation: | 22 |
| (1) mecloqualone; | 23 |
| (2) methaqualone; and | 24 |
| (3) gamma hydroxybutyric acid. | 25 |
| (f) Unless specifically excepted or unless listed in | 26 |
| another schedule,
any material, compound, mixture, or |
|
|
|
HB6459 Engrossed |
- 10 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| preparation which contains any quantity
of the following | 2 |
| substances having a stimulant effect on the central nervous
| 3 |
| system, including its salts, isomers, and salts of isomers: | 4 |
| (1) Fenethylline; | 5 |
| (2) N-ethylamphetamine; | 6 |
| (3) Aminorex (some other names:
| 7 |
| 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| 8 |
| 4-5-dihydro-5-phenyl-2-oxazolamine) and its
| 9 |
| salts, optical isomers, and salts of optical isomers; | 10 |
| (4) Methcathinone (some other names:
| 11 |
| 2-methylamino-1-phenylpropan-1-one;
| 12 |
| Ephedrone; 2-(methylamino)-propiophenone;
| 13 |
| alpha-(methylamino)propiophenone; N-methylcathinone;
| 14 |
| methycathinone; Monomethylpropion; UR 1431) and its
| 15 |
| salts, optical isomers, and salts of optical isomers; | 16 |
| (5) Cathinone (some trade or other names:
| 17 |
| 2-aminopropiophenone; alpha-aminopropiophenone;
| 18 |
| 2-amino-1-phenyl-propanone; norephedrone); | 19 |
| (6) N,N-dimethylamphetamine (also known as:
| 20 |
| N,N-alpha-trimethyl-benzeneethanamine;
| 21 |
| N,N-alpha-trimethylphenethylamine); | 22 |
| (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| 23 |
| 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine). | 24 |
| (g) Temporary listing of substances subject to emergency | 25 |
| scheduling.
Any material, compound, mixture, or preparation | 26 |
| that contains any quantity
of the following substances: |
|
|
|
HB6459 Engrossed |
- 11 - |
LRB096 21101 RLC 36952 b |
|
| 1 |
| (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| 2 |
| (benzylfentanyl), its optical isomers, isomers, salts,
| 3 |
| and salts of isomers; | 4 |
| (2) N-[1(2-thienyl)
| 5 |
| methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| 6 |
| its optical isomers, salts, and salts of isomers. | 7 |
| (Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07; | 8 |
| 96-347, eff. 1-1-10.)
|
|